MentionFox
Home › funding signals › BioStack Platforms
Accelerator · announced

BioStack Platforms (YC X26) — Real world training envs for healthcare AI models

BioStack is building the data engine for healthcare and drug discovery AI. The bottleneck is not models.

BioStack Platforms is a Y Combinator company in the Spring 2026 batch. Its directory entry describes it as: Real world training envs for healthcare AI models. The founders listed are Sanat Mishra (Founder/CEO), Parth Patwa (Founder/CTO) (Y Combinator directory entry, March 26, 2026).

6 more companies from YC Spring 2026 ↓

Run the free check on BioStack Platforms →

Sell to companies like BioStack Platforms? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

BioStack Platforms

New accelerator entry · 2026-03-26 · the record

Spring 2026
batch
11
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchSpring 2026
Announced2026-03-26
StageEarly
StatusActive
Team size11
IndustryHealthcare
Sub-industryHealthcare
RegionsUnited States of America, America / Canada
BasedSan Francisco, CA, USA
HiringYes
Founded2025
YC group partnerNicolas Dessaigne

Pitching, partnering or investing alongside them? See who really runs and owns BioStack Platforms.

Free to see. No signup.

Keep reading

More on BioStack Platforms and the records around it.

Also in YC Spring 2026

Same batch, Healthcare first.

What do you want to do with BioStack Platforms?

Get the full cited report on BioStack Platforms

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on BioStack Platforms: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

BioStack is building the data engine for healthcare and drug discovery AI. The bottleneck is not models. It is access to high-quality biological data. Clinical and experimental data is fragmented, unstructured, and locked inside hospitals, labs, and CROs, while generating new data is slow and expensive. BioStack fixes this with proprietary clinical and preclinical data pipelines that turn real biomedical workflows into ML-ready training environments. We structure longitudinal multimodal data across imaging, EHR, and experimental assays, then package it for post-training and reinforcement learning so models can learn how research and care actually happen. Instead of static datasets, BioStack gives AI labs workflow-aligned data and environments that improve reasoning, decision-making, and real-world performance in biology and medicine.

Want the whole picture on BioStack Platforms?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on BioStack Platforms: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on BioStack Platforms covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind BioStack Platforms: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for BioStack Platforms. With no account yet, you sign up free and land on the result.

On these startup lists

Healthcare and health tech startups Biotech startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

BioStack Platforms: Accepted into Y Combinator Spring 2026
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-biostack-platforms
Last updated 2026-10-29
Primary record: Y Combinator directory entry
BioStack Platforms (YC X26) — Real world training envs for healthcare AI models. MentionFox, 2026-10-29. https://mentionfox.com/funding/yc-biostack-platforms